BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: He Q, Chen HY, Bai EQ, Luo YX, Fu RJ, He YS, Jiang J, Wang HQ. Development of a multiplex MethyLight assay for the detection of multigene methylation in human colorectal cancer. Cancer Genet Cytogenet. 2010;202:1-10. [PMID: 20804913 DOI: 10.1016/j.cancergencyto.2010.05.018] [Cited by in Crossref: 69] [Cited by in F6Publishing: 67] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 Jiang F, Yang X, He X, Yang M. Circulating DNA, a Potentially Sensitive and Specific Diagnostic Tool for Future Medicine. Dose Response 2019;17:1559325819891010. [PMID: 31827416 DOI: 10.1177/1559325819891010] [Reference Citation Analysis]
2 Pellino G, Gallo G, Pallante P, Capasso R, De Stefano A, Maretto I, Malapelle U, Qiu S, Nikolaou S, Barina A, Clerico G, Reginelli A, Giuliani A, Sciaudone G, Kontovounisios C, Brunese L, Trompetto M, Selvaggi F. Noninvasive Biomarkers of Colorectal Cancer: Role in Diagnosis and Personalised Treatment Perspectives. Gastroenterol Res Pract. 2018;2018:2397863. [PMID: 30008744 DOI: 10.1155/2018/2397863] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 8.3] [Reference Citation Analysis]
3 De Mattos-Arruda L, Olmos D, Tabernero J. Prognostic and predictive roles for circulating biomarkers in gastrointestinal cancer. Future Oncol 2011;7:1385-97. [PMID: 22112315 DOI: 10.2217/fon.11.122] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
4 Worm Ørntoft MB. Review of Blood-Based Colorectal Cancer Screening: How Far Are Circulating Cell-Free DNA Methylation Markers From Clinical Implementation? Clin Colorectal Cancer 2018;17:e415-33. [PMID: 29678513 DOI: 10.1016/j.clcc.2018.02.012] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 6.8] [Reference Citation Analysis]
5 Nunes SP, Moreira-Barbosa C, Salta S, Palma de Sousa S, Pousa I, Oliveira J, Soares M, Rego L, Dias T, Rodrigues J, Antunes L, Henrique R, Jerónimo C. Cell-Free DNA Methylation of Selected Genes Allows for Early Detection of the Major Cancers in Women. Cancers (Basel) 2018;10:E357. [PMID: 30261643 DOI: 10.3390/cancers10100357] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 5.5] [Reference Citation Analysis]
6 Tóth K, Wasserkort R, Sipos F, Kalmár A, Wichmann B, Leiszter K, Valcz G, Juhász M, Miheller P, Patai ÁV, Tulassay Z, Molnár B. Detection of methylated septin 9 in tissue and plasma of colorectal patients with neoplasia and the relationship to the amount of circulating cell-free DNA. PLoS One 2014;9:e115415. [PMID: 25526039 DOI: 10.1371/journal.pone.0115415] [Cited by in Crossref: 67] [Cited by in F6Publishing: 68] [Article Influence: 8.4] [Reference Citation Analysis]
7 Azuara D, Rodriguez-Moranta F, de Oca J, Sanjuan X, Guardiola J, Lobaton T, Wang A, Boadas J, Piqueras M, Monfort D. Novel methylation panel for the early detection of neoplasia in high-risk ulcerative colitis and Crohn’s colitis patients. Inflamm Bowel Dis. 2013;19:165-173. [PMID: 22532293 DOI: 10.1002/ibd.22994] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
8 Müller D, Győrffy B. DNA methylation-based diagnostic, prognostic, and predictive biomarkers in colorectal cancer. Biochim Biophys Acta Rev Cancer 2022;:188722. [PMID: 35307512 DOI: 10.1016/j.bbcan.2022.188722] [Reference Citation Analysis]
9 Song L, Jia J, Peng X, Xiao W, Li Y. The performance of the SEPT9 gene methylation assay and a comparison with other CRC screening tests: A meta-analysis. Sci Rep. 2017;7:3032. [PMID: 28596563 DOI: 10.1038/s41598-017-03321-8] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 10.8] [Reference Citation Analysis]
10 Bach S, Sluiter NR, Beagan JJ, Mekke JM, Ket JCF, van Grieken NCT, Steenbergen RDM, Ylstra B, Kazemier G, Tuynman JB. Circulating Tumor DNA Analysis: Clinical Implications for Colorectal Cancer Patients. A Systematic Review. JNCI Cancer Spectr 2019;3:pkz042. [PMID: 32328554 DOI: 10.1093/jncics/pkz042] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
11 Nian J, Sun X, Ming S, Yan C, Ma Y, Feng Y, Yang L, Yu M, Zhang G, Wang X. Diagnostic Accuracy of Methylated SEPT9 for Blood-based Colorectal Cancer Detection: A Systematic Review and Meta-Analysis. Clin Transl Gastroenterol. 2017;8:e216. [PMID: 28102859 DOI: 10.1038/ctg.2016.66] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 8.8] [Reference Citation Analysis]
12 Ng JM, Yu J. Promoter hypermethylation of tumour suppressor genes as potential biomarkers in colorectal cancer. Int J Mol Sci. 2015;16:2472-2496. [PMID: 25622259 DOI: 10.3390/ijms16022472] [Cited by in Crossref: 85] [Cited by in F6Publishing: 81] [Article Influence: 12.1] [Reference Citation Analysis]
13 Esposito A, Bardelli A, Criscitiello C, Colombo N, Gelao L, Fumagalli L, Minchella I, Locatelli M, Goldhirsch A, Curigliano G. Monitoring tumor-derived cell-free DNA in patients with solid tumors: clinical perspectives and research opportunities. Cancer Treat Rev 2014;40:648-55. [PMID: 24184333 DOI: 10.1016/j.ctrv.2013.10.003] [Cited by in Crossref: 73] [Cited by in F6Publishing: 66] [Article Influence: 8.1] [Reference Citation Analysis]
14 Laugsand EA, Brenne SS, Skorpen F. DNA methylation markers detected in blood, stool, urine, and tissue in colorectal cancer: a systematic review of paired samples. Int J Colorectal Dis 2021;36:239-51. [PMID: 33030559 DOI: 10.1007/s00384-020-03757-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
15 Lind GE, Danielsen SA, Ahlquist T, Merok MA, Andresen K, Skotheim RI, Hektoen M, Rognum TO, Meling GI, Hoff G. Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas. Mol Cancer. 2011;10:85. [PMID: 21777459 DOI: 10.1186/1476-4598-10-85] [Cited by in Crossref: 82] [Cited by in F6Publishing: 79] [Article Influence: 7.5] [Reference Citation Analysis]
16 Danese E, Montagnana M. Epigenetics of colorectal cancer: emerging circulating diagnostic and prognostic biomarkers. Ann Transl Med 2017;5:279. [PMID: 28758105 DOI: 10.21037/atm.2017.04.45] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
17 Constâncio V, Nunes SP, Henrique R, Jerónimo C. DNA Methylation-Based Testing in Liquid Biopsies as Detection and Prognostic Biomarkers for the Four Major Cancer Types. Cells 2020;9:E624. [PMID: 32150897 DOI: 10.3390/cells9030624] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 11.5] [Reference Citation Analysis]
18 Song L, Yu H, Jia J, Li Y. A systematic review of the performance of the SEPT9 gene methylation assay in colorectal cancer screening, monitoring, diagnosis and prognosis. Cancer Biomark. 2017;18:425-432. [PMID: 28128742 DOI: 10.3233/cbm-160321] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
19 Sun GP, Tang YX, Meng J, Liang GF, Zhang YW, Lu XB, Li XX. WITHDRAWN: SEPT9 DNA methylation as an early diagnostic marker in colorectal cancer. Cancer Genet 2015:S2210-7762(15)00026-5. [PMID: 25908231 DOI: 10.1016/j.cancergen.2015.02.005] [Reference Citation Analysis]
20 Hu J, Hu B, Gui YC, Tan ZB, Xu JW. Diagnostic Value and Clinical Significance of Methylated SEPT9 for Colorectal Cancer: A Meta-Analysis. Med Sci Monit 2019;25:5813-22. [PMID: 31378778 DOI: 10.12659/MSM.915472] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
21 Snellenberg S, De Strooper LM, Hesselink AT, Meijer CJ, Snijders PJ, Heideman DA, Steenbergen RD. Development of a multiplex methylation-specific PCR as candidate triage test for women with an HPV-positive cervical scrape. BMC Cancer 2012;12:551. [PMID: 23176198 DOI: 10.1186/1471-2407-12-551] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 4.2] [Reference Citation Analysis]
22 Galanopoulos M, Tsoukalas N, Papanikolaou IS, Tolia M, Gazouli M, Mantzaris GJ. Abnormal DNA methylation as a cell-free circulating DNA biomarker for colorectal cancer detection: A review of literature. World J Gastrointest Oncol 2017; 9(4): 142-152 [PMID: 28451061 DOI: 10.4251/wjgo.v9.i4.142] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
23 Desplats PA. Perinatal programming of neurodevelopment: epigenetic mechanisms and the prenatal shaping of the brain. Adv Neurobiol 2015;10:335-61. [PMID: 25287548 DOI: 10.1007/978-1-4939-1372-5_16] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
24 Martignano F. Cell-Free DNA: An Overview of Sample Types and Isolation Procedures. Methods Mol Biol 2019;1909:13-27. [PMID: 30580420 DOI: 10.1007/978-1-4939-8973-7_2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
25 Dong L, Ren H. Blood-based DNA Methylation Biomarkers for Early Detection of Colorectal Cancer. J Proteomics Bioinform 2018;11:120-6. [PMID: 30034186 DOI: 10.4172/jpb.1000477] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
26 Gallardo-Gómez M, De Chiara L, Álvarez-Chaver P, Cubiella J. Colorectal cancer screening and diagnosis: omics-based technologies for development of a non-invasive blood-based method. Expert Rev Anticancer Ther 2021;21:723-38. [PMID: 33507120 DOI: 10.1080/14737140.2021.1882858] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Syedmoradi L, Esmaeili F, Norton ML. Towards DNA methylation detection using biosensors. Analyst 2016;141:5922-43. [PMID: 27704092 DOI: 10.1039/c6an01649a] [Cited by in Crossref: 22] [Cited by in F6Publishing: 2] [Article Influence: 5.5] [Reference Citation Analysis]
28 Yan S, Liu Z, Yu S, Bao Y. Diagnostic Value of Methylated Septin9 for Colorectal Cancer Screening: A Meta-Analysis. Med Sci Monit 2016;22:3409-18. [PMID: 27665580 DOI: 10.12659/msm.900590] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
29 Lee HS, Hwang SM, Kim TS, Kim DW, Park DJ, Kang SB, Kim HH, Park KU. Circulating methylated septin 9 nucleic Acid in the plasma of patients with gastrointestinal cancer in the stomach and colon. Transl Oncol. 2013;6:290-296. [PMID: 23730408 DOI: 10.1593/tlo.13118] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 4.6] [Reference Citation Analysis]
30 Olkhov-Mitsel E, Zdravic D, Kron K, van der Kwast T, Fleshner N, Bapat B. Novel multiplex MethyLight protocol for detection of DNA methylation in patient tissues and bodily fluids. Sci Rep. 2014;4:4432. [PMID: 24651255 DOI: 10.1038/srep04432] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
31 Wang X, Kuang YY, Hu XT. Advances in epigenetic biomarker research in colorectal cancer. World J Gastroenterol 2014; 20(15): 4276-4287 [PMID: 24764665 DOI: 10.3748/wjg.v20.i15.4276] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
32 Connolly D, Yang Z, Castaldi M, Simmons N, Oktay MH, Coniglio S, Fazzari MJ, Verdier-Pinard P, Montagna C. Septin 9 isoform expression, localization and epigenetic changes during human and mouse breast cancer progression. Breast Cancer Res. 2011;13:R76. [PMID: 21831286 DOI: 10.1186/bcr2924] [Cited by in Crossref: 69] [Cited by in F6Publishing: 61] [Article Influence: 6.3] [Reference Citation Analysis]
33 Salta S, P Nunes S, Fontes-Sousa M, Lopes P, Freitas M, Caldas M, Antunes L, Castro F, Antunes P, Palma de Sousa S, Henrique R, Jerónimo C. A DNA Methylation-Based Test for Breast Cancer Detection in Circulating Cell-Free DNA. J Clin Med 2018;7:E420. [PMID: 30405052 DOI: 10.3390/jcm7110420] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
34 Rasmussen SL, Krarup HB, Sunesen KG, Pedersen IS, Madsen PH, Thorlacius-Ussing O. Hypermethylated DNA as a biomarker for colorectal cancer: a systematic review. Colorectal Dis. 2016;18:549-561. [PMID: 26998585 DOI: 10.1111/codi.13336] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 7.0] [Reference Citation Analysis]
35 Singh A, Gupta S, Sachan M. Evaluation of the Diagnostic Potential of Candidate Hypermethylated Genes in Epithelial Ovarian Cancer in North Indian Population. Front Mol Biosci 2021;8:719056. [PMID: 34778370 DOI: 10.3389/fmolb.2021.719056] [Reference Citation Analysis]
36 Marcuello M, Vymetalkova V, Neves RPL, Duran-Sanchon S, Vedeld HM, Tham E, van Dalum G, Flügen G, Garcia-Barberan V, Fijneman RJ, Castells A, Vodicka P, Lind GE, Stoecklein NH, Heitzer E, Gironella M. Circulating biomarkers for early detection and clinical management of colorectal cancer. Mol Aspects Med 2019;69:107-22. [PMID: 31189073 DOI: 10.1016/j.mam.2019.06.002] [Cited by in Crossref: 65] [Cited by in F6Publishing: 62] [Article Influence: 21.7] [Reference Citation Analysis]
37 Qi JH, Wang YP, Lu QM. Hypermethylated tumor suppressor genes as potential biomarkers in colorectal cancer. Shijie Huaren Xiaohua Zazhi 2016; 24(16): 2506-2512 [DOI: 10.11569/wcjd.v24.i16.2506] [Reference Citation Analysis]
38 Sobanski T, Arantes LMRB, Dos Santos W, Matsushita M, de Oliveira MA, Costa M, de Carvalho AC, Berardinelli GN, Syrjänen K, Reis RM, Guimarães DP. Methylation profile of colon cancer genes in colorectal precursor lesions and tumor tissue: perspectives for screening. Scand J Gastroenterol 2021;56:920-8. [PMID: 34218733 DOI: 10.1080/00365521.2021.1922744] [Reference Citation Analysis]
39 Noehammer C, Pulverer W, Hassler MR, Hofner M, Wielscher M, Vierlinger K, Liloglou T, McCarthy D, Jensen TJ, Nygren A, Gohlke H, Trooskens G, Braspenning M, Van Criekinge W, Egger G, Weinhaeusel A. Strategies for validation and testing of DNA methylation biomarkers. Epigenomics 2014;6:603-22. [PMID: 25531255 DOI: 10.2217/epi.14.43] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
40 Schwarzenbach H, Hoon DS, Pantel K. Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer. 2011;11:426-437. [PMID: 21562580 DOI: 10.1038/nrc3066] [Cited by in Crossref: 1666] [Cited by in F6Publishing: 1574] [Article Influence: 151.5] [Reference Citation Analysis]
41 Mansour H. Cell-free nucleic acids as noninvasive biomarkers for colorectal cancer detection. Front Genet. 2014;5:182. [PMID: 25221563 DOI: 10.3389/fgene.2014.00182] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
42 Menéndez P, Villarejo P, Padilla D, Menéndez JM, Rodríguez Montes JA. Epigenética y cáncer colorrectal. Cirugía Española 2012;90:277-83. [DOI: 10.1016/j.ciresp.2011.11.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
43 Li B, Gan A, Chen X, Wang X, He W, Zhang X, Huang R, Zhou S, Song X, Xu A. Diagnostic Performance of DNA Hypermethylation Markers in Peripheral Blood for the Detection of Colorectal Cancer: A Meta-Analysis and Systematic Review. PLoS One. 2016;11:e0155095. [PMID: 27158984 DOI: 10.1371/journal.pone.0155095] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
44 Xue M, Lai SC, Xu ZP, Wang LJ. Noninvasive DNA methylation biomarkers in colorectal cancer: A systematic review. J Dig Dis 2015;16:699-712. [PMID: 26565661 DOI: 10.1111/1751-2980.12299] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
45 Masliah E, Dumaop W, Galasko D, Desplats P. Distinctive patterns of DNA methylation associated with Parkinson disease: identification of concordant epigenetic changes in brain and peripheral blood leukocytes. Epigenetics 2013;8:1030-8. [PMID: 23907097 DOI: 10.4161/epi.25865] [Cited by in Crossref: 192] [Cited by in F6Publishing: 169] [Article Influence: 21.3] [Reference Citation Analysis]
46 Gabriel E, Bagaria SP. Assessing the Impact of Circulating Tumor DNA (ctDNA) in Patients With Colorectal Cancer: Separating Fact From Fiction. Front Oncol. 2018;8:297. [PMID: 30128304 DOI: 10.3389/fonc.2018.00297] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
47 Ryan EJ, Creagh EM. Emerging methods in colorectal cancer screening. Br J Surg 2018;105:e16-8. [PMID: 29341154 DOI: 10.1002/bjs.10650] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
48 Paska AV, Hudler P. Aberrant methylation patterns in cancer: a clinical view. Biochem Med (Zagreb) 2015;25:161-76. [PMID: 26110029 DOI: 10.11613/BM.2015.017] [Cited by in Crossref: 52] [Cited by in F6Publishing: 30] [Article Influence: 7.4] [Reference Citation Analysis]
49 García-Giménez JL, Seco-Cervera M, Tollefsbol TO, Romá-Mateo C, Peiró-Chova L, Lapunzina P, Pallardó FV. Epigenetic biomarkers: Current strategies and future challenges for their use in the clinical laboratory. Crit Rev Clin Lab Sci 2017;54:529-50. [PMID: 29226748 DOI: 10.1080/10408363.2017.1410520] [Cited by in Crossref: 44] [Cited by in F6Publishing: 32] [Article Influence: 8.8] [Reference Citation Analysis]
50 Danese E, Minicozzi AM, Benati M, Montagnana M, Paviati E, Salvagno GL, Lima-Oliveira G, Gusella M, Pasini F, Lippi G, Guidi GC. Comparison of genetic and epigenetic alterations of primary tumors and matched plasma samples in patients with colorectal cancer. PLoS One 2015;10:e0126417. [PMID: 25946211 DOI: 10.1371/journal.pone.0126417] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
51 Bach S, Paulis I, Sluiter NR, Tibbesma M, Martin I, van de Wiel MA, Tuynman JB, Bahce I, Kazemier G, Steenbergen RDM. Detection of colorectal cancer in urine using DNA methylation analysis. Sci Rep 2021;11:2363. [PMID: 33504902 DOI: 10.1038/s41598-021-81900-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
52 Sun G, Meng J, Duan H, Zhang D, Tang Y. Diagnostic Assessment of septin9 DNA Methylation for Colorectal Cancer Using Blood Detection: A Meta-Analysis. Pathol Oncol Res 2019;25:1525-34. [PMID: 30488278 DOI: 10.1007/s12253-018-0559-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
53 Zhang M, He Y, Zhang X, Zhang M, Kong L. A pooled analysis of the diagnostic efficacy of plasmic methylated septin-9 as a novel biomarker for colorectal cancer. Biomed Rep. 2017;7:353-360. [PMID: 29085631 DOI: 10.3892/br.2017.970] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
54 Gutierrez A, Demond H, Brebi P, Ili CG. Novel Methylation Biomarkers for Colorectal Cancer Prognosis. Biomolecules 2021;11:1722. [PMID: 34827720 DOI: 10.3390/biom11111722] [Reference Citation Analysis]
55 Singh A, Gupta S, Badarukhiya JA, Sachan M. Detection of aberrant methylation of HOXA9 and HIC1 through multiplex MethyLight assay in serum DNA for the early detection of epithelial ovarian cancer. Int J Cancer 2020;147:1740-52. [PMID: 32191343 DOI: 10.1002/ijc.32984] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
56 Chen HY, Zhu BH, Zhang CH, Yang DJ, Peng JJ, Chen JH, Liu FK, He YL. High CpG island methylator phenotype is associated with lymph node metastasis and prognosis in gastric cancer. Cancer Sci. 2012;103:73-79. [PMID: 22017425 DOI: 10.1111/j.1349-7006.2011.02129.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 3.3] [Reference Citation Analysis]
57 Jung G, Hernández-Illán E, Moreira L, Balaguer F, Goel A. Epigenetics of colorectal cancer: biomarker and therapeutic potential. Nat Rev Gastroenterol Hepatol 2020;17:111-30. [PMID: 31900466 DOI: 10.1038/s41575-019-0230-y] [Cited by in Crossref: 97] [Cited by in F6Publishing: 112] [Article Influence: 48.5] [Reference Citation Analysis]
58 Migheli F, Migliore L. Epigenetics of colorectal cancer. Clin Genet 2012;81:312-8. [PMID: 22263639 DOI: 10.1111/j.1399-0004.2011.01829.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 4.1] [Reference Citation Analysis]
59 Liu HY, Zhang CJ. Identification of differentially expressed genes and their upstream regulators in colorectal cancer. Cancer Gene Ther 2017;24:244-50. [DOI: 10.1038/cgt.2017.8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
60 Herbst A, Kolligs FT. Detection of DNA hypermethylation in remote media of patients with colorectal cancer: new biomarkers for colorectal carcinoma. Tumour Biol. 2012;33:297-305. [PMID: 22362383 DOI: 10.1007/s13277-012-0346-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
61 Connolly D, Abdesselam I, Verdier-Pinard P, Montagna C. Septin roles in tumorigenesis. Biol Chem 2011;392:725-38. [PMID: 21740328 DOI: 10.1515/BC.2011.073] [Cited by in Crossref: 60] [Cited by in F6Publishing: 33] [Article Influence: 5.5] [Reference Citation Analysis]
62 Xue M, Wang LJ. Value of DNA methylation markers in colorectal cancer screening. Shijie Huaren Xiaohua Zazhi 2015; 23(29): 4626-4635 [DOI: 10.11569/wcjd.v23.i29.4626] [Reference Citation Analysis]
63 Yuan H, Kuete M, Su L, Yang F, Hu Z, Tian B, Zhang H, Zhao K. Comparison of three different techniques of human sperm DNA isolation for methylation assay. J Huazhong Univ Sci Technol [Med Sci ] 2015;35:938-42. [DOI: 10.1007/s11596-015-1532-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
64 Salehi R, Atapour N, Vatandoust N, Farahani N, Ahangari F, Salehi AR. Methylation pattern of ALX4 gene promoter as a potential biomarker for blood-based early detection of colorectal cancer. Adv Biomed Res 2015;4:252. [PMID: 26918234 DOI: 10.4103/2277-9175.170677] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
65 Wang J, Han X, Sun Y. DNA methylation signatures in circulating cell-free DNA as biomarkers for the early detection of cancer. Sci China Life Sci 2017;60:356-62. [DOI: 10.1007/s11427-016-0253-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
66 Rawson JB, Bapat B. Epigenetic biomarkers in colorectal cancer diagnostics. Expert Rev Mol Diagn. 2012;12:499-509. [PMID: 22702366 DOI: 10.1586/erm.12.39] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
67 Vidaki A, Kalamara V, Carnero-Montoro E, Spector TD, Bell JT, Kayser M. Investigating the Epigenetic Discrimination of Identical Twins Using Buccal Swabs, Saliva, and Cigarette Butts in the Forensic Setting. Genes (Basel) 2018;9:E252. [PMID: 29758014 DOI: 10.3390/genes9050252] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
68 Zhu Y, Yang T, Wu Q, Yang X, Hao J, Deng X, Yang S, Gu C, Wang Z. Diagnostic performance of various liquid biopsy methods in detecting colorectal cancer: A meta-analysis. Cancer Med 2020;9:5699-707. [PMID: 32628360 DOI: 10.1002/cam4.3276] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
69 Perez-Carbonell L, Balaguer F, Toiyama Y, Egoavil C, Rojas E, Guarinos C, Andreu M, Llor X, Castells A, Jover R. IGFBP3 methylation is a novel diagnostic and predictive biomarker in colorectal cancer. PLoS One. 2014;9:e104285. [PMID: 25127039 DOI: 10.1371/journal.pone.0104285] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
70 Zhan YX, Luo GH. DNA methylation detection methods used in colorectal cancer. World J Clin Cases 2019; 7(19): 2916-2929 [PMID: 31624740 DOI: 10.12998/wjcc.v7.i19.2916] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
71 Gan X, Wang T, Chen Z, Zhang K. Blood-derived molecular signatures as biomarker panels for the early detection of colorectal cancer. Mol Biol Rep 2020;47:8159-68. [DOI: 10.1007/s11033-020-05838-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]